Nu Holdings stock ticks up as Nubank maps $475 million office push and lands Ironman title deal
27 January 2026
1 min read

Nu Holdings stock ticks up as Nubank maps $475 million office push and lands Ironman title deal

New York, Jan 27, 2026, 11:05 ET — Regular session

  • Shares of Nu Holdings edged up roughly 0.7% in late morning trading as investors absorbed news of the company’s plan to expand its Brazil office.
  • Nubank revealed plans to invest over R$2.5 billion in office and infrastructure costs across the next five years
  • The company revealed it will be the title sponsor for Ironman Brazil in 2026, linking the event to its Ultravioleta premium segment

Nu Holdings (NU.N) shares climbed roughly 0.7%, hitting $18.31 by late morning Tuesday, following the announcement of a major office expansion in Brazil.

This spending shift is significant, revealing Nubank’s updated plan for expanding its workforce and infrastructure following years of remote-first work. Investors have viewed Nu mainly as a growth play, but adding substantial fixed costs could quickly alter that narrative.

Nu spent the past 24 hours highlighting a second focus: expanding its reach among premium customers. The latest move, a new sports sponsorship tied to its Ultravioleta segment, adds a fresh entry to its strategy—and sets up another trial of returns.

Nubank announced Monday that it plans to pour over 2.5 billion reais (around $475 million) into expanding and modernizing its Brazilian office network over the next five years. The bank will also roll out a hybrid work model in 2026, blending office and remote work. “Investing in physical spaces is investing in our capacity to innovate,” said Livia Chanes, Nubank Brazil’s CEO. 1

On Tuesday, Nubank announced Nubank Ultravioleta as the title sponsor for the IRONMAN circuit and TRIDAY Series across Brazil starting in 2026. The deal will span 10 events. Nubank CMO Juliana Roschel highlighted that “sports and wellness are priorities for our customers.” Carlos Galvão, CEO of Unlimited Sports, described the partnership as “a milestone for Brazilian triathlon.” 2

Nu Holdings, a holding company based in Brazil, offers digital banking services spanning spending, saving, investing, borrowing, and protection, Reuters reports. It faces competition from major Brazilian banks as well as a packed fintech landscape vying for deposits and wealthy clients. 3

The broader market is pulling some weight too. U.S. stocks showed mixed results as investors braced for the Federal Reserve’s upcoming policy call, a key event that tends to shift sentiment on high-growth financial shares one way or the other. 4

There’s a risk, though. Expanding office space drives up operating costs, locking in expenses just as investors turn harsh on margin dips. Plus, the impact of marketing partnerships isn’t easy to quantify every quarter.

Nu is gearing up for its next major event: the quarterly update. According to the investor calendar, the company will release its fourth-quarter results and hold a conference call on Feb. 25. 5

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Palantir stock ticks up as Fed decision and Feb. 2 earnings near — what PLTR traders watch next
Previous Story

Palantir stock ticks up as Fed decision and Feb. 2 earnings near — what PLTR traders watch next

JPMorgan stock price slips below $300 as Fed decision and Trump lawsuit keep banks in focus
Next Story

JPMorgan stock price slips below $300 as Fed decision and Trump lawsuit keep banks in focus

Go toTop